Reykjavik’s Decode genetics is to be acquired by a major US pharmaceutical giant. According to a report by the Chicago Tribune on Monday, California-based Amgen Inc has agreed to buy the genetics agency in a cash deal worth USD 415 million (EUR 320 million).